9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 89 filers reported holding 9 METERS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $159,000 | -38.8% | 724,492 | -27.5% | 0.00% | – |
Q2 2022 | $260,000 | -43.2% | 999,759 | +31.1% | 0.00% | – |
Q1 2022 | $458,000 | -71.2% | 762,654 | -53.0% | 0.00% | – |
Q4 2021 | $1,588,000 | -11.5% | 1,623,100 | +17.6% | 0.00% | – |
Q3 2021 | $1,794,000 | -30.5% | 1,380,146 | -41.2% | 0.00% | – |
Q2 2021 | $2,582,000 | -16.0% | 2,347,149 | -10.6% | 0.00% | – |
Q1 2021 | $3,072,000 | +891.0% | 2,625,293 | +628.8% | 0.00% | – |
Q4 2020 | $310,000 | +134.8% | 360,200 | +122.3% | 0.00% | – |
Q3 2020 | $132,000 | +450.0% | 162,000 | +283.0% | 0.00% | – |
Q2 2020 | $24,000 | – | 42,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
Almanack Investment Partners, LLC. | 40,850 | $53,000 | 0.01% |